Insulin Receptor Substrate-2 Mediated Phosphatidylinositol-3-kinase Signaling Selectively Inhibits Glycogen Synthase Kinase-3{beta} to Regulate Aerobic Glycolysis [Metabolism]

May 8th, 2014 by Landis, J., Shaw, L. M.

Insulin Receptor Substrate-1 (IRS-1) and IRS-2 are cytoplasmic adaptor proteins that mediate the activation of signaling pathways in response to ligand stimulation of upstream cell surface receptors. Despite sharing a high level of homology and the ability to activate PI3K, only Irs-2 positively regulates aerobic glycolysis in mammary tumor cells. To determine the contribution of Irs-2-dependent PI3K signaling to this selective regulation, we generated an Irs-2 mutant deficient in the recruitment of PI3K. We identified four tyrosine residues (Y649, Y671, Y734 and Y814) that are essential for the association of PI3K with Irs-2 and demonstrate that combined mutation of these tyrosines inhibits glucose uptake and lactate production, two measures of aerobic glycolysis. Irs-2-dependent activation of PI3K regulates the phosphorylation of specific Akt substrates, most notably Glycogen synthase kinase-3β (Gsk-3β). Inhibition of Gsk-3β by Irs-2-dependent PI3K signaling promotes glucose uptake and aerobic glycolysis. The regulation of unique subsets of Akt substrates by Irs-1 and Irs-2 may explain their non-redundant roles in mammary tumor biology. Taken together, our study reveals a novel mechanism by which Irs-2 signaling preferentially regulates tumor cell metabolism and adds to our understanding of how this adaptor protein contributes to breast cancer progression.
  • Posted in Journal of Biological Chemistry, Publications
  • Comments Off on Insulin Receptor Substrate-2 Mediated Phosphatidylinositol-3-kinase Signaling Selectively Inhibits Glycogen Synthase Kinase-3{beta} to Regulate Aerobic Glycolysis [Metabolism]